March 16th 2023
Lawyers were questioned in a federal lawsuit intending to overturn approval of a drug used for medication abortion; during the COVID-19 pandemic in 2021, US maternal mortality increased for the third year in a row; the Alzheimer’s Association is lobbying Congress to push for Medicare coverage of new Alzheimer drugs under early access.
What We’re Reading: J&J Ends HIV Vaccine Trial; Deaths After Abortion Bans; Sanofi Looks to Hemophilia A DrugJanuary 19th 2023
Johnson & Johnson (J&J) ends late-stage HIV vaccine trial; mothers in states with abortion bans are almost 3 times more likely to die before, during, and after birth; Sanofi hopes to release a drug for hemophilia A in 2023.
What We’re Reading: ACA Marketplaces’ Record Enrollment; Antiabortion Protests at CVS, Walgreens; Alzheimer Drug Gets Expensive Price TagJanuary 11th 2023
Expanded health coverage sees an increase in enrollments; Antiabortion activists protest against CVS and Walgreens; $26,500 Alzheimer’s drug limits affordability
Frequency of Condomless Sex Among Women Using Reversible Methods of ContraceptionJanuary 6th 2023
A substudy of the Evidence for Contraceptive Options and HIV Outcomes trial, which compared 3 highly effective, reversible methods of contraception, concluded that women assigned either a copper intrauterine device or the levonorgestrel implant may have had condomless sex more frequently than women assigned to intramuscular depo-medroxyprogesterone acetate.
Limited Appointment Availability and Cost Largest Obstacles to Women’s Mental Health CareJanuary 5th 2023
In the last 2 years, half of women reported needing mental health services compared with only 35% of men. Women who needed mental health care cited provider availability and cost, especially for those who are uninsured, to be 2 major barriers to receiving care.
What We’re Reading: Spurring Development of Antibiotics; Legislation to Protect IVF; Vaccine Misinformation Poses ThreatDecember 16th 2022
Bipartisan lawmakers aim to pass bill that could incentivize development of new antibiotics; the right to use in vitro fertilization (IVF) may be enshrined in law; CDC director says that vaccine misinformation is a public health threat.
Genealogical Study of Primary Ovarian Insufficiency Suggests Strong Genetic ComponentDecember 2nd 2022
The population-level, mutigenerational study found that both near and distant relatives of women with primary ovarian insufficiency were at a higher risk of the condition compared with matched controls.
Women With CKD Receiving Fertility Treatment Have Similar Birth Rates to Those Conceiving NaturallyNovember 28th 2022
Researchers underscore a need for prospective data, noting that women with chronic kidney disease (CKD) tended to have higher rates of preterm delivery and lower birthweight.
Unintended Pregnancy May Increase Risk of Postpartum Depression, Study FindsNovember 26th 2022
The risk of experiencing symptoms of postpartum depression may be higher in women who give birth after unintended pregnancies vs those who get pregnant intentionally, according to a recent study.
Review Highlights Need for Further Research, Individualized Treatments for Endometriosis-Associated InfertilityNovember 22nd 2022
Although there is a clinically recognized association between endometriosis and infertility, the mechanisms behind the association are not fully understood.
Study Examines Maternal Health Care Disparities by Immigrant, Medicaid StatusOctober 28th 2022
Exclusions from Medicaid eligibility based on immigration status may be linked with increased health care disparities among immigrant women compared with US-born women, a study suggested.
What We’re Reading: Experts Advise on Pregnancy Drug; Novavax COVID-19 Booster Approved; Allergy Medication and OpioidsOctober 20th 2022
Experts advised the FDA to withdraw a preterm birth treatment from the market; the Novavax booster for COVID-19 was approved by US regulators on Wednesday; allergy medication was found to be commonly present in those who died of an opioid overdose.
What We’re Reading: Biden Biodefense Strategy; Racial Disparities in Fertility Medicine; Global Leaders Pledge to End PolioOctober 19th 2022
The White House launched a national biodefense strategy to protect the country from future pandemics and biological threats; researchers found racial disparities in infant deaths following fertility treatments; global leaders pledged a total of $2.6 billion toward the Global Polio Eradication Initiative’s 2022-2026 Strategy.